LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity

Liver-expressed antimicrobial peptide 2 (LEAP-2), originally described as an antimicrobial peptide, has recently been recognized as an endogenous blocker of growth hormone secretagogue receptor 1a (GHS-R1a). GHS-R1a, also known as ghrelin receptor, is a G protein-coupled receptor (GPCR) widely distr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xuehan, Huang, Lili, Huang, Zhengxiang, Feng, Dandan, Clark, Richard J., Chen, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428150/
https://www.ncbi.nlm.nih.gov/pubmed/34512549
http://dx.doi.org/10.3389/fendo.2021.717544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428150/
https://www.ncbi.nlm.nih.gov/pubmed/34512549
http://dx.doi.org/10.3389/fendo.2021.717544

Ejemplares similares